Publications by authors named "Adrian D Cook"

Claim this Profile
D
Duration of Androgen Suppression with Postoperative Radiotherapy (DADSPORT) for Nonmetastatic Prostate Cancer: A Collaborative Systematic Review and Meta-analysis of Aggregate Data.
Sarah Burdett, David J Fisher, Jayne F Tierney, Adrian D Cook, Daniel E Spratt

Eur Urol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomised Trial of No, Short-term, or Long-term Androgen Deprivation Therapy with Postoperative Radiotherapy After Radical Prostatectomy: Results from the Three-way Comparison of RADICALS-HD (NCT00541047).
Chris C Parker, Noel W Clarke, Adrian D Cook, Peter M Petersen, Charles N Catton

Eur Urol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial.
Chris C Parker, Howard Kynaston, Adrian D Cook, Noel W Clarke, Charles N Catton

Lancet· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial.
Chris C Parker, Noel W Clarke, Adrian D Cook, Howard Kynaston, Charles N Catton

Lancet· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage Radiation Therapy After Radical Prostatectomy: Analysis of Toxicity by Dose-Fractionation in the RADICALS-RT Trial.
Peter Meidahl Petersen, Adrian D Cook, Matthew R Sydes, Noel Clarke, William Cross

Int J Radiat Oncol Biol Phys· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal cancer treatment (ICON8): overall survival results from an open-label, randomised, controlled, phase 3 trial.
Andrew R Clamp, Elizabeth C James, Iain A McNeish, Andrew Dean, Jae-Won Kim, Adrian D Cook

Lancet Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of Life in Men With Prostate Cancer Randomly Allocated to Receive Docetaxel or Abiraterone in the STAMPEDE Trial.
Hannah L Rush, Laura Murphy, Alicia K Morgans, Noel W Clarke, Adrian D Cook

J Clin Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Objective responses to first-line neoadjuvant carboplatin-paclitaxel regimens for ovarian, fallopian tube, or primary peritoneal carcinoma (ICON8): post-hoc exploratory analysis of a randomised, phase 3 trial.
Robert D Morgan, Iain A McNeish, Adrian D Cook, Elizabeth C James, Rosemary Lord

Lancet Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial.
Christopher C Parker, Noel W Clarke, Adrian D Cook, Howard G Kynaston, Peter Meidahl Petersen, Peter W Cooke

Lancet· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression-free survival in the ICON8 trial - Authors' reply.
Elizabeth C James, Iain A McNeish, Adrian D Cook, Richard Kaplan, Andrew R Clamp

Lancet· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overlap between adverse events (AEs) and serious adverse events (SAEs): a case study of a phase III cancer clinical trial.
Elizabeth C James, David Dunn, Adrian D Cook, Andrew R Clamp, Matthew R Sydes

Trials· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weekly platinum-based chemotherapy versus 3-weekly platinum-based chemotherapy for newly diagnosed ovarian cancer (ICON8): quality-of-life results of a phase 3, randomised, controlled trial.
Sarah P Blagden, Adrian D Cook, Christopher Poole, Lesley Howells, Ian A McNeish

Lancet Oncol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab for Newly Diagnosed Ovarian Cancers: Best Candidates Among High-Risk Disease Patients (ICON-7).
Olivier Colomban, Michel Tod, Julien Peron, Timothy J Perren, Alexandra Leary, Adrian D Cook

JNCI Cancer Spectr· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial.
Andrew R Clamp, Elizabeth C James, Iain A McNeish, Andrew Dean, Jae-Weon Kim, Adrian D Cook

Lancet· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory biomarkers in HIV-infected children hospitalized for severe malnutrition in Uganda and Zimbabwe.
Andrew J Prendergast, Chipo Berejena, Godfrey Pimundu, Annie Shonhai, Mutsa Bwakura-Dangarembizi, Adrian D Cook

AIDS· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial.
Veronica Mulenga, Victor Musiime, Adeodata Kekitiinwa, Adrian D Cook, George Abongomera

Lancet Infect Dis· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discordance between the results and conclusions of ICON7 - Authors' reply.
Amit M Oza, Adrian D Cook, Richard Kaplan, Mahesh K B Parmar, Timothy J Perren

Lancet Oncol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial.
Amit M Oza, Adrian D Cook, Jacobus Pfisterer, Andrew Embleton, Jonathan A Ledermann

Lancet Oncol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hospitalization for severe malnutrition among HIV-infected children starting antiretroviral therapy.
Andrew Prendergast, Mutsa F Bwakura-Dangarembizi, Adrian D Cook, Sabrina Bakeera-Kitaka, Eva Natukunda

AIDS· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis